Bryce Point Capital »

Supernus Pharmaceuticals shares owned by Bryce Point Capital

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Bryce Point Capital from 13F filings

Historical chart of Bryce Point Capital investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Bryce Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Bryce Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $269k 5.6k 47.79